A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Clinical trial NCT07169708 · RECRUITING
Trial details
- NCT number
- NCT07169708
- Sponsor
- Ono Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-03-20
- Primary completion
- 2026-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.